Well beyond tomorrow

At SynDermix, our vision is to deliver breakthrough innovation that addresses patient convenience equally well to efficacy and safety in areas of major unmet medical need

SynDermix is a Swiss developer of innovative health technologies that focuses on the development of effective and safe treatments that meaningfully respect patient convenience and address important unmet medical needs.

About us

Latest events and updates

First Site Initiation Visit (SIV) Completed for the Clinical Trial of SDX-3101 in Austria 7 January, 2020 in Updates

SynDermix AG is pleased to announce the successful completion of the first SIV for the clinical trial of SDX-3101, in preparation for the recruitment of the first patient to the study. (more…)

Collaboration with King’s College London on the Formulation Development of SDX-21 1 July, 2019 in Updates

SynDermix AG is proud to announce its collaboration with King’s College London for the development of its Nitric Oxide technology. (more…)

AGM 2019: Re-election of Chairman and Board of Directors 11 June, 2019 in Updates

Shareholders approve all proposals put forward by the Board of Directors and re-elect the Chairman and Directors to the board of SynDermix.

Our platform technologies